Search Results - Momtaz, Parisa

Immunologic checkpoints in cancer therapy: focus on the programmed death-1 (PD-1) receptor pathway by Momtaz, Parisa, Postow, Michael A

Get full text Get full text Get full text

Safety of Infusing Ipilimumab Over 30 Minutes by Momtaz, Parisa, Park, Vivian, Panageas, Katherine S., Postow, Michael A., Callahan, Margaret, Wolchok, Jedd D., Chapman, Paul B.

Get full text Get full text Get full text

Patterns of long-term survival following Ipilimumab (Ipi): the Memorial Sloan Kettering Cancer Center 10-year metastatic melanoma (MM) experience by Page, David B, Naidoo, Jarushka, Momtaz, Parisa, Bogatch, Kita, Kuk, Deborah, Panageas, Katherine, Yuan, Jianda, Wolchok, Jedd D, Postow, Michael

Get full text Get full text

Quantification of tumor-derived cell free DNA(cfDNA) by digital PCR (DigPCR) in cerebrospinal fluid of patients with BRAF(V600) mutated malignancies by Momtaz, Parisa, Pentsova, Elena, Abdel-Wahab, Omar, Diamond, Eli, Hyman, David, Merghoub, Taha, You, Daoqi, Gasmi, Billel, Viale, Agnes, Chapman, Paul B.

Get full text Get full text Get full text

Measuring Toxic Effects and Time to Treatment Failure for Nivolumab Plus Ipilimumab in Melanoma by Shoushtari, Alexander N., Friedman, Claire F., Navid-Azarbaijani, Pedram, Postow, Michael A., Callahan, Margaret K., Momtaz, Parisa, Panageas, Katherine S., Wolchok, Jedd D., Chapman, Paul B.

Get full text Get full text Get full text

Checkpoint blockade in melanoma patients with underlying chronic lymphocytic leukemia by Smithy, James W., Pianko, Matthew J., Maher, Colleen, Postow, Michael A., Shoushtari, Alexander N., Momtaz, Parisa, Chapman, Paul B., Wolchok, Jedd D., Park, Jae H., Callahan, Margaret K.

Get full text Get full text Get full text

Thinking Critically About Classifying Adverse Events: Incidence of Pancreatitis in Patients Treated With Nivolumab + Ipilimumab by Friedman, Claire F., Clark, Varina, Raikhel, Andrew V., Barz, Tim, Shoushtari, Alexander N., Momtaz, Parisa, Callahan, Margaret K., Wolchok, Jedd D., Chapman, Paul B., Hellmann, Matthew D., Postow, Michael A.

Get full text Get full text Get full text

Four-month course of adjuvant dabrafenib in patients with surgically resected stage IIIC melanoma characterized by a BRAFV600E/K mutation by Momtaz, Parisa, Harding, James J., Ariyan, Charlotte, Coit, Daniel G., Merghoub, Taha, Gasmi, Billel, You, Daoqi, Viale, Agnes, Panageas, Katherine S., Samoila, Aliaksandra, Postow, Michael A., Wolchok, Jedd D., Chapman, Paul B.

Get full text Get full text Get full text

Survival Outcomes After Metastasectomy in Melanoma Patients Categorized by Response to Checkpoint Blockade by Bello, Danielle M., Panageas, Katherine S., Hollmann, Travis, Shoushtari, Alexander N., Momtaz, Parisa, Chapman, Paul B., Postow, Michael A., Callahan, Margaret K., Wolchok, Jedd D., Brady, Mary S., Coit, Daniel G., Ariyan, Charlotte E.

Get full text Get full text Get full text

Long-Term Outcomes and Responses to Retreatment in Patients With Melanoma Treated With PD-1 Blockade by Betof Warner, Allison, Palmer, Jessica S., Shoushtari, Alexander N., Goldman, Debra A., Panageas, Katherine S., Hayes, Sara A., Bajwa, Raazi, Momtaz, Parisa, Callahan, Margaret K., Wolchok, Jedd D., Postow, Michael A., Chapman, Paul B.

Get full text Get full text Get full text

Prognosis of Mucosal, Uveal, Acral, Nonacral Cutaneous, and Unknown Primary Melanoma From the Time of First Metastasis by Kuk, Deborah, Shoushtari, Alexander N., Barker, Christopher A., Panageas, Katherine S., Munhoz, Rodrigo R., Momtaz, Parisa, Ariyan, Charlotte E., Brady, Mary Sue, Coit, Daniel G., Bogatch, Kita, Callahan, Margaret K., Wolchok, Jedd D., Carvajal, Richard D., Postow, Michael A.

Get full text Get full text Get full text

Immune-Related Adverse Events, Need for Systemic Immunosuppression, and Effects on Survival and Time to Treatment Failure in Patients With Melanoma Treated With Ipilimumab at Memor... by Horvat, Troy Z., Adel, Nelly G., Dang, Thu-Oanh, Momtaz, Parisa, Postow, Michael A., Callahan, Margaret K., Carvajal, Richard D., Dickson, Mark A., D'Angelo, Sandra P., Woo, Kaitlin M., Panageas, Katherine S., Wolchok, Jedd D., Chapman, Paul B.

Get full text Get full text Get full text

PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma by Catalanotti, Federica, Cheng, Donavan T., Shoushtari, Alexander N., Johnson, Douglas B., Panageas, Katherine S., Momtaz, Parisa, Higham, Catherine, Won, Helen H., Harding, James J., Merghoub, Taha, Rosen, Neal, Sosman, Jeffrey A., Berger, Michael F., Chapman, Paul B., Solit, David B.

Get full text Get full text Get full text

Adaptive Dosing of Nivolumab + Ipilimumab Immunotherapy Based Upon Early, Interim Radiographic Assessment in Advanced Melanoma (The ADAPT-IT Study) by Postow, Michael A., Goldman, Debra A., Shoushtari, Alexander N., Betof Warner, Allison, Callahan, Margaret K., Momtaz, Parisa, Smithy, James W., Naito, Ellesa, Cugliari, Marina K., Raber, Vladislav, Eton, Omar, Nair, Suresh G., Panageas, Katherine S., Wolchok, Jedd D., Chapman, Paul B.

Get full text Get full text Get full text

Therapeutic Implications of Detecting MAP Kinase Activating Alterations in Cutaneous and Unknown Primary Melanomas by Shoushtari, Alexander N., Chatila, Walid K., Arora, Arshi, Sanchez-Vega, Francisco, Kantheti, Havish, Zamalloa, Jorge Rojas, Krieger, Penina, Callahan, Margaret K., Warner, Allison Betof, Postow, Michael A., Momtaz, Parisa, Nair, Suresh, Ariyan, Charlotte, Barker, Christopher, Brady, Mary Susan, Coit, Daniel, Rosen, Neal, Chapman, Paul B., Busam, Klaus, Solit, David B., Panageas, Katherine S., Wolchok, Jedd D., Schultz, Nikolaus

Get full text Get full text Get full text

LAG-3 expression on peripheral blood cells identifies patients with poorer outcomes after immune checkpoint blockade. by Shen, Ronglai, Postow, Michael A., Adamow, Matthew, Arora, Arshi, Hannum, Margaret, Maher, Colleen, Wong, Phillip, Curran, Michael A., Hollmann, Travis J., Jia, Liwei, Al-Ahmadie, Hikmat, Keegan, Niamh, Funt, Samuel A., Iyer, Gopa, Rosenberg, Jonathan E., Bajorin, Dean F., Chapman, Paul B., Shoushtari, Alexander N., Betof, Allison S., Momtaz, Parisa, Merghoub, Taha, Wolchok, Jedd D., Panageas, Katherine S., Callahan, Margaret K.

Get full text Get full text Get full text

A Prospective, Phase 1 Trial of Nivolumab, Ipilimumab, and Radiotherapy in Patients with Advanced Melanoma by Postow, Michael A., Knox, Susan J., Goldman, Debra A., Elhanati, Yuval, Mavinkurve, Vikram, Wong, Phillip, Halpenny, Darragh, Reddy, Sunil K., Vado, Kenya, McCabe, Danielle, Aufiero Ramirez, Kristen, Macri, Mary, Schwarzenberger, Paul, Ricciardi, Toni, Ryan, Aileen, Venhaus, Ralph, Momtaz, Parisa, Shoushtari, Alexander N., Callahan, Margaret K., Chapman, Paul B., Wolchok, Jedd D., Subrahmanyam, Priyanka B., Maecker, Holden T., Panageas, Katherine S., Barker, Christopher A.

Get full text Get full text Get full text

First-line pembrolizumab and trastuzumab in HER2-positive esophagogastric cancer by Janjigian, Yelena Y., Maron, Steven B., Chatila, Walid K., Millang, Brittanie, Chavan, Shweta S., Alterman, Carly, Chou, Joanne F., Simmons, Marc, Momtaz, Parisa, Shcherba, Marina, Ku, Geoffrey Y., Zervoudakis, Alice, Won, Elizabeth S., Kelsen, David P., Ilson, David H., Nagy, Rebecca J., Lanman, Richard B., Ptashkin, Ryan N., Donoghue, Mark T.A., Capanu, Marinela, Taylor, Barry S., Solit, David B., Schultz, Nikolaus, Hechtman, Jaclyn F.

Get full text Get full text Get full text

Defibrotide for the Treatment of Severe Hepatic Veno-Occlusive Disease and Multiorgan Failure after Stem Cell Transplantation: A Multicenter, Randomized, Dose-Finding Trial by Richardson, Paul G., Soiffer, Robert J., Antin, Joseph H., Uno, Hajime, Jin, Zhezhen, Kurtzberg, Joanne, Martin, Paul L., Steinbach, Gideon, Murray, Karen F., Vogelsang, Georgia B., Chen, Allen R., Krishnan, Amrita, Kernan, Nancy A., Avigan, David E., Spitzer, Thomas R., Shulman, Howard M., Di Salvo, Donald N., Revta, Carolyn, Warren, Diane, Momtaz, Parisa, Bradwin, Gary, Wei, L. J., Iacobelli, Massimo, McDonald, George B., Guinan, Eva C.

Get full text Get full text Get full text

Pancreas Cancer and BRCA: A Critical Subset of Patients With Improving Therapeutic Outcomes by Momtaz, Parisa, O’Connor, Catherine A., Chou, Joanne F., Capanu, Marinela, Park, Wungki, Bandlamudi, Chaitanya, Berger, Michael F., Kelsen, David P., Suehnholz, Sarah P., Chakravarty, Debyani, Yu, Kenneth H., Varghese, Anna M., Zervoudakis, Alice, Li, Jia, Ku, Geoffrey Y., Park, Jennifer S., Shcherba, Marina, Harding, James J., Goldberg, Zoe, Abou-Alfa, Ghassan K., Salo-Mullen, Erin E., Stadler, Zsofia K., Iacobuzio-Donahue, Christine A., O’Reilly, Eileen M.

Get full text Get full text Get full text